PD-L1 Testing in Lung Cancer
This video reviews the use of PD-L1 testing in selecting patients for frontline lung cancer treatment with pembrolizumab and examines which patients might not be appropriate for immunotherapy.
In this video, Aaron S. Mansfield, MD, of the Mayo Clinic in Rochester, Minnesota, reviews PD-L1 testing in selecting patients for frontline lung cancer treatment with pembrolizumab, and discusses which patients might not be appropriate for immunotherapy.
Mansfield spoke on this topic last month at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
September 18th 2018ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.
